XML 21 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance, shares at Dec. 31, 2018 60,609            
Beginning balance, value at Dec. 31, 2018 $ 1   $ 90,756 $ (60,765) $ (11)   $ 29,981
Net income (loss)       (6,296)     (6,296)
Shares issued for stock options exercised, shares 134            
Shares issued for stock options exercised, value     216       216
Agent growth incentive stock compensation, shares 136            
Agent growth incentive stock compensation, value     3,669       3,669
Stock option compensation     1,215       1,215
Agent equity stock compensation, shares 620            
Agent equity stock compensation, value     6,210       6,210
Foreign currency translation gain (loss)         15   15
Repurchase of common stock, shares   358          
Repurchase of common stock, value   $ (3,647)         (3,647)
Ending balance, shares at Mar. 31, 2019 61,499 358          
Ending balance, value at Mar. 31, 2019 $ 1 $ (3,647) 102,066 (67,061) 4   31,363
Beginning balance, shares at Dec. 31, 2018 60,609            
Beginning balance, value at Dec. 31, 2018 $ 1   90,756 (60,765) (11)   29,981
Net income (loss)             (8,492)
Foreign currency translation gain (loss)             63
Ending balance, shares at Jun. 30, 2019 63,120 818          
Ending balance, value at Jun. 30, 2019 $ 1 $ (8,545) 118,408 (69,256) 52   40,660
Beginning balance, shares at Mar. 31, 2019 61,499 358          
Beginning balance, value at Mar. 31, 2019 $ 1 $ (3,647) 102,066 (67,061) 4   31,363
Net income (loss)       (2,195)     (2,195)
Shares issued for stock options exercised, shares 537            
Shares issued for stock options exercised, value     690       690
Agent growth incentive stock compensation, shares 149            
Agent growth incentive stock compensation, value     3,587       3,587
Stock option compensation     1,831       1,831
Agent equity stock compensation, shares 935            
Agent equity stock compensation, value     10,234       10,234
Foreign currency translation gain (loss)         48   48
Repurchase of common stock, shares   460          
Repurchase of common stock, value   $ (4,898)         (4,898)
Ending balance, shares at Jun. 30, 2019 63,120 818          
Ending balance, value at Jun. 30, 2019 $ 1 $ (8,545) 118,408 (69,256) 52   40,660
Beginning balance, shares at Dec. 31, 2019 66,199 925          
Beginning balance, value at Dec. 31, 2019 $ 1 $ (8,623) 130,682 (70,293) 200 $ 161 52,128
Net income (loss)       165   (23) 142
Shares issued for stock options exercised, shares 1,785            
Shares issued for stock options exercised, value     1,828       1,828
Agent growth incentive stock compensation, shares 127            
Agent growth incentive stock compensation, value     2,551       2,551
Stock option compensation     1,073       1,073
Agent equity stock compensation, shares 917            
Agent equity stock compensation, value     8,794       8,794
Foreign currency translation gain (loss)         (297)   (297)
Repurchase of common stock, shares   991          
Repurchase of common stock, value   $ (10,305)         (10,305)
Contributions by noncontrolling interests           86 86
Ending balance, shares at Mar. 31, 2020 69,028 1,916          
Ending balance, value at Mar. 31, 2020 $ 1 $ (18,928) 144,928 (70,128) (97) 224 56,000
Beginning balance, shares at Dec. 31, 2019 66,199 925          
Beginning balance, value at Dec. 31, 2019 $ 1 $ (8,623) 130,682 (70,293) 200 161 52,128
Net income (loss)             8,377
Foreign currency translation gain (loss)             $ (53)
Repurchase of common stock, shares             1,122
Repurchase of common stock, value             $ (11,987)
Ending balance, shares at Jun. 30, 2020 70,579 2,047          
Ending balance, value at Jun. 30, 2020 $ 1 $ (20,610) 160,643 (61,853) 147 204 78,532
Beginning balance, shares at Mar. 31, 2020 69,028 1,916          
Beginning balance, value at Mar. 31, 2020 $ 1 $ (18,928) 144,928 (70,128) (97) 224 56,000
Net income (loss)       8,275   (40) 8,235
Shares issued for stock options exercised, shares 415            
Shares issued for stock options exercised, value     639       639
Agent growth incentive stock compensation, shares 208            
Agent growth incentive stock compensation, value     3,346       3,346
Stock option compensation     1,227       1,227
Agent equity stock compensation, shares 928            
Agent equity stock compensation, value     10,503       10,503
Foreign currency translation gain (loss)         244   $ 244
Repurchase of common stock, shares   131         131
Repurchase of common stock, value   $ (1,682)         $ (1,682)
Contributions by noncontrolling interests           20 20
Ending balance, shares at Jun. 30, 2020 70,579 2,047          
Ending balance, value at Jun. 30, 2020 $ 1 $ (20,610) $ 160,643 $ (61,853) $ 147 $ 204 $ 78,532